Efrat Dotan

9k citations
112 papers · 6.6k · 5 hit papers · h-index 30

Impact in

  • Oncology top 0.5%
    • Pancreatic and Hepatic Oncology Research
    • Cancer survivorship and care
    • Colorectal Cancer Treatments and Studies
    • Cancer Immunotherapy and Biomarkers
    • Frailty in Older Adults

Papers in

    • Pancreatic and Hepatic Oncology Research 23
    • Colorectal Cancer Treatments and Studies 18
    • Cancer survivorship and care 8
    • Colorectal Cancer Surgical Treatments 6
    • Cancer Immunotherapy and Biomarkers 4
    • Frailty in Older Adults 26

Efrat Dotan

105 papers receiving 6.5k citations

Efrat Dotan's Hit Papers

An open-label study of pemigatinib in cholangiocarcinoma: final results from FIGHT-202 2024 · 48 citations
480+3+7Years since publication4008001.2k

Peers

Efrat Dotan
Comparison fields: 5 of 113
  • Oncology 3.2k
  • Geriatrics and Gerontology 450
  • Surgery 1.3k
  • Cancer Research 391
  • Radiology, Nuclear Medicine and Imaging 269
Replace Halfdan Sørbye with:
Halfdan Sørbye Norway
Maartje Los Netherlands
Kristopher M. Attwood United States
Hanna Kelly Sanoff United States
Marianne G. Guren Norway
Sungjin Kim United States
Benjamin R. Tan United States
Richard Francis Dunne United States
Campbell S.D. Roxburgh United Kingdom
Monika Martha Engelhardt Germany
Efrat Dotan relative to Halfdan Sørbye Norway Halfdan Sørbye's profile →
Citations per field
00.5×2×4×5.2×
Halfdan Sørbye · 1×
Citations per year

Countries citing papers authored by Efrat Dotan

Since Specialization
Citations

This map shows the geographic impact of Efrat Dotan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Efrat Dotan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Efrat Dotan more than expected).

Fields of papers citing papers by Efrat Dotan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Efrat Dotan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Efrat Dotan. The network helps show where Efrat Dotan may publish in the future.

Co-authors

The 25 scholars most cited alongside Efrat Dotan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Efrat Dotan Line = papers co-authored together Efrat Dotan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 112 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
Hit paper breakdown →
20201235
2
Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Hit paper breakdown →
2021931
3
Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
Hit paper breakdown →
2017820
4
Cancer-Related Fatigue, Version 2.2015
Hit paper breakdown →
2015733
5 2019320
6 2014241
7 2021152
8
Impact of Rituximab (Rituxan) on the Treatment of B-Cell Non-Hodgkin's Lymphoma.
2010127
9 2014119
10 2021103
11 202098
12 201796
13 201692
14 201188
15 201988
16 202066
17 200963
18 202261
19 201652
20 201250

About Efrat Dotan

Efrat Dotan is a scholar working on Oncology, Geriatrics and Gerontology, Cancer Research, Surgery and Physiology, having authored 112 papers that have together received 6.6k indexed citations. Recurring topics across this work include Frailty in Older Adults (26 papers), Pancreatic and Hepatic Oncology Research (23 papers), Colorectal Cancer Treatments and Studies (18 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers), Cancer survivorship and care (8 papers), Colorectal Cancer Surgical Treatments (6 papers), Cancer Genomics and Diagnostics (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). The work is most often cited by research in Oncology (3.2k citations), Geriatrics and Gerontology (450 citations), Surgery (1.3k citations), Cancer Research (391 citations) and Radiology, Nuclear Medicine and Imaging (269 citations). Efrat Dotan has collaborated with scholars based in United States, France and South Korea. Frequent co-authors include Steven J. Cohen, Mitesh J. Borad, Antoine Hollebecque, Vaibhav Sahai, Do‐Youn Oh, Ghassan K. Abou-Alfa, Davide Melisi, David H. Gallinson, Gina M. Vaccaro and Daniel V.T. Catenacci. Their work appears in journals such as Journal of Geriatric Oncology, Journal of the National Comprehensive Cancer Network, Journal of Clinical Oncology, Annals of Oncology and Journal of Palliative Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact